| P50 | author | Wooin Lee | Q43136341 |
| P2093 | author name string | Chang-Guo Zhan | |
| | Kyung-Bo Kim | |
| | Lalit Kumar Sharma | |
| | Eun Ryoung Jang | |
| | Beilei Lei | |
| | Na-Ra Lee | |
| P2860 | cites work | Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress | Q24296668 |
| | Imaging proteins inside cells with fluorescent tags | Q24617820 |
| | Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity | Q27677313 |
| | Lack of proteasome active site allostery as revealed by subunit-specific inhibitors | Q32138849 |
| | Profiling proteasome activity in tissue with fluorescent probes | Q33294646 |
| | Immunoproteasomes: regulating the regulator | Q33879127 |
| | Activity-based protein profiling for biochemical pathway discovery in cancer | Q34493489 |
| | Molecular mechanisms of proteasome assembly | Q34928594 |
| | Activity-based protein profiling: applications to biomarker discovery, in vivo imaging and drug discovery | Q36009873 |
| | Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors | Q36237082 |
| | Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing | Q36266425 |
| | Tagging and detection strategies for activity-based proteomics. | Q36686285 |
| | A critical role for the inducible proteasomal subunits LMP7 and MECL1 in cytokine production by activated murine splenocytes | Q36984148 |
| | Proteasome modulators: essential chemical genetic tools for understanding human diseases | Q37114679 |
| | Activity-based protein profiling: from enzyme chemistry to proteomic chemistry | Q37119021 |
| | Catalytic mechanism and assembly of the proteasome. | Q37407654 |
| | The proteasomal system. | Q37446143 |
| | The 26 S proteasome: from basic mechanisms to drug targeting | Q37610623 |
| | Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs). | Q37830068 |
| | The immunoproteasome: an emerging therapeutic target | Q37913443 |
| | Immune and non-immune functions of the immunoproteasome | Q37971596 |
| | A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes | Q38712612 |
| | Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome | Q39813739 |
| | Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations. | Q42420033 |
| | Imaging 26S proteasome activity and inhibition in living mice | Q44486478 |
| | Immunoproteasome-specific inhibitors and their application. | Q53184413 |
| | Proteasomes in immune cells: more than peptide producers? | Q53354360 |
| | Active-site directed probes to report enzymatic action in the ubiquitin proteasome system. | Q53538898 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunoproteasome | Q106087471 |
| P304 | page(s) | 1899-1903 | |
| P577 | publication date | 2012-07-17 | |
| P1433 | published in | ChemBioChem | Q634395 |
| P1476 | title | Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells | |
| P478 | volume | 13 | |